InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,319.56
(
-0.03%
)
US TECH 100
18,232.80
(
0.00%
)
Dow Jones
39,843.36
(
-0.07%
)
Brent Oil
82.13
(
-0.39%
)
Bitcoin
70,213.84
(
0.12%
)
Post# of 459613
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

imho

Send PM Follow Ignore
Followers 10
Posts 778
Boards Moderated 0
Alias Born 03/18/2003

imho

Re: PeterKarol post# 88778

Wednesday, 01/25/2017 9:48:56 PM

Wednesday, January 25, 2017 9:48:56 PM

Post# of 459613

The cost of phase2/3 for central nervous system drug cost on average $13,000 per patient.


Per month, correct? So I calculate $47 million/year for n=300. This may be on low end? I have seen as high as $25000 per patient when I googled it.

IMHO
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

Start posting your company's news
Only $200 per official company press release!